A groundbreaking study provides the scientific basis for using noninvasive eye imaging to detect the pathological hallmarks of Alzheimer’s disease. Experimental technology developed by Cedars-Sinai and NeuroVision scans the retina using techniques that can identify beta-amyloid protein deposits that mirror those in the brain.
Read More-->>
Comments
Post a Comment